




Searching News Database: Neurogen
HSMN NewsFeed - 7 Feb 2022
Vensica Closes $19 Million Round with Investment from Strategic Partner Merz
Vensica Closes $19 Million Round with Investment from Strategic Partner Merz
HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
HSMN NewsFeed - 15 Oct 2019
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
HSMN NewsFeed - 11 Sep 2018
Vertos Medical Announces MILD(R) Procedure Long-term Safety and Efficacy Data
Vertos Medical Announces MILD(R) Procedure Long-term Safety and Efficacy Data
HSMN NewsFeed - 8 Mar 2018
Spinal Singularity Treats First Patient in Clinical Feasibility Study in US
Spinal Singularity Treats First Patient in Clinical Feasibility Study in US
HSMN NewsFeed - 2 Oct 2017
Biohaven Reports Negative Topline Data from Spinocerebellar Ataxia (SCA) Phase 2/3 Trial
Biohaven Reports Negative Topline Data from Spinocerebellar Ataxia (SCA) Phase 2/3 Trial
HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
HSMN NewsFeed - 4 Feb 2015
Concert Pharmaceuticals Announces Appointment of James V. Cassella as Chief Development Officer
Concert Pharmaceuticals Announces Appointment of James V. Cassella as Chief Development Officer
HSMN NewsFeed - 5 Nov 2014
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
HSMN NewsFeed - 27 Jan 2014
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
HSMN NewsFeed - 23 May 2013
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
HSMN NewsFeed - 10 Sep 2012
A.P. Pharma Appoints Thomas Pitler, Ph.D. as Vice President of Business Development
A.P. Pharma Appoints Thomas Pitler, Ph.D. as Vice President of Business Development
HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
HSMN NewsFeed - 30 Mar 2009
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
HSMN NewsFeed - 12 Sep 2008
Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
HSMN NewsFeed - 30 Jun 2008
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
HSMN NewsFeed - 28 Mar 2008
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
HSMN NewsFeed - 10 Mar 2008
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
HSMN NewsFeed - 4 Feb 2008
Neurogen Corporation Announces Appointment of Stephen R. Davis as President & CEO
Neurogen Corporation Announces Appointment of Stephen R. Davis as President & CEO
HSMN NewsFeed - 3 Jan 2008
Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
HSMN NewsFeed - 12 Nov 2007
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
HSMN NewsFeed - 29 Oct 2007
VertiFlex Commercially Releases Superion(TM), a Percutaneously Delivered Interspinous Spacer
VertiFlex Commercially Releases Superion(TM), a Percutaneously Delivered Interspinous Spacer
HSMN NewsFeed - 27 Sep 2007
BrainCells Inc., Taisho Pharmaceutical Co., Ltd. Sign Licensing Agreement for Novel CNS Program
BrainCells Inc., Taisho Pharmaceutical Co., Ltd. Sign Licensing Agreement for Novel CNS Program
HSMN NewsFeed - 17 Sep 2007
Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
HSMN NewsFeed - 14 Sep 2007
Neurogen Corporation Announces Appointment of Stephen R. Davis as President
Neurogen Corporation Announces Appointment of Stephen R. Davis as President
HSMN NewsFeed - 30 Aug 2007
Neurogen Corporation Announces Appointment of George D. Maynard to Vice President
Neurogen Corporation Announces Appointment of George D. Maynard to Vice President
HSMN NewsFeed - 14 Aug 2007
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
HSMN NewsFeed - 30 May 2007
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
HSMN NewsFeed - 2 May 2007
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
HSMN NewsFeed - 28 Nov 2006
Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legs Syndrome
Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legs Syndrome
HSMN NewsFeed - 13 Oct 2006
Pfizer Names Senior Executive to Head Expanded Worldwide Licensing and Business Development
Pfizer Names Senior Executive to Head Expanded Worldwide Licensing and Business Development
Additional items found! 27

Members Archive contains
27 additional stories matching:
Neurogen
(Password required)
Neurogen
(Password required)